Search by Drug Name or NDC

    NDC 00085-4331-01 NOXAFIL 18 mg/mL Details

    NOXAFIL 18 mg/mL

    NOXAFIL is a INTRAVENOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is POSACONAZOLE.

    Product Information

    NDC 00085-4331
    Product ID 0085-4331_50e517fb-4c04-4639-9359-e20907ca822e
    Associated GPIs 11407060002020
    GCN Sequence Number 072141
    GCN Sequence Number Description posaconazole VIAL 300MG/16.7 INTRAVEN
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 36248
    HICL Sequence Number 033461
    HICL Sequence Number Description POSACONAZOLE
    Brand/Generic Brand
    Proprietary Name NOXAFIL
    Proprietary Name Suffix n/a
    Non-Proprietary Name posaconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 18
    Active Ingredient Units mg/mL
    Substance Name POSACONAZOLE
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205596
    Listing Certified Through 2024-12-31

    Package

    NDC 00085-4331-01 (00085433101)

    NDC Package Code 0085-4331-01
    Billing NDC 00085433101
    Package 1 VIAL, GLASS in 1 CARTON (0085-4331-01) / 16.7 mL in 1 VIAL, GLASS
    Marketing Start Date 2014-03-13
    NDC Exclude Flag N
    Pricing Information N/A